Skip to main content
Igor Laskowski, MD, Vascular Surgery, Valhalla, NY

Igor A Laskowski MD


Attending Surgeon Chief, Section of Endovascular Surgery, Westchester Medical Center, Associate Professor of Surgery, New York Medical College

Join to View Full Profile
  • 100 Woods RdFl 1Valhalla, NY 10595

  • Phone+1 914-909-6900

  • Fax+1 914-493-2828

Dr. Laskowski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Vascular Surgery - Independent, 2006 - 2007
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2001 - 2006
  • Harvard Medical School
    Harvard Medical SchoolPost-Doctoral Fellowship, 1998 - 2001
  • Medical University of Warsaw
    Medical University of WarsawClass of 1996

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2004 - 2026
  • Surgery
    American Board of Surgery Surgery
  • Vascular Surgery
    American Board of Surgery Vascular Surgery
  • RPVI
    ARDMSRPVI
  • RVT
    ARDMSRVT

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Conolly, 2017
  • Regional Top Doctor Castle Connolly, 2014
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Westchester Medical Center and BioGenCell Open BioGenCell's Fourth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United States
    Westchester Medical Center and BioGenCell Open BioGenCell's Fourth Chronic Limb-Threatening Ischemia Clinical Trial Site in the United StatesSeptember 6th, 2023
  • WMC and BioGenCell Open Chronic Limb-Threatening Ischemia Trial Site
    WMC and BioGenCell Open Chronic Limb-Threatening Ischemia Trial SiteSeptember 8th, 2023

Professional Memberships

Other Languages

  • Polish

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: